International Clinical Trial: CT-AI Breast Cancer Opportunistic Screening Health Examination Study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07809698) titled 'CT-AI Breast Cancer Opportunistic Screening Health Examination Study' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Screening. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital with Nanjing Medical University

Condition: Breast Neoplasms

Intervention: Device: CT-AI-assisted breast cancer screening

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 1, 2026

Target Sample Size: 30000

To know more, visit https://clinicaltrials.gov/study/NCT07809698

Disclaimer: Curat...